The U.S. Food and Drug Administration (FDA) agreed to speed up the review of Roche's Tecentriq, the immunotherapy drug intended for metastatic urothelial carcinoma.
High volume hospitals and doctors improve surgical outcomes for patients with bladder cancer, a new study reported.
Invisible blood in urine may be an early warning sign of bladder cancer, according to a new study.
Patients with muscle-invasive bladder cancer are normally benefitted from chemotherapy before surgery to remove the tumor. However, in a test of one regimen by researchers at Fox Chase Cancer Center was halted after too many patients experienced serious side effects such as heart attacks and blood clots in the legs and lungs.
A single type of cell in the lining of the bladder is responsible for most cases of deadly bladder cancer, according to a new research.
Urine tests may recognize aggressive and less aggressive bladder cancers, a new study suggests.
Women who eat lots of fruits and vegetables are less likely to develop invasive bladder cancer, a new study suggests.
A new scent device could help diagnose patients with early signs of bladder cancer.
Researchers stressed that better treatment compliance within the first two years post bladder cancer diagnosis could lead to reduced death rates and recurrences.
A surgeon at Mount Sinai Medical Center, one of New York City’s most esteemed hospitals, has been summarily dismissed from his duties after it came to light that he removed the wrong kidney from a patient.
Herbal medicine is commonly considered to be safe.